Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
18.36
-0.12 (-0.65%)
At close: Dec 15, 2025, 4:00 PM EST
18.36
0.00 (0.00%)
After-hours: Dec 15, 2025, 4:04 PM EST
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $1.01 billion as of December 15, 2025. Its market cap has decreased by -9.62% in one year.
Market Cap
1.01B
Enterprise Value
717.60M
1-Year Change
-9.62%
Ranking
Category
Stock Price
$18.36
Market Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has increased from $931.70M to $1.01B, an increase of 7.95%. That is a compound annual growth rate of 6.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 1.01B | 6.80% |
| Dec 31, 2024 | 947.92M | 1.74% |
| Sep 13, 2024 | 931.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |